推荐产品
等级
pharmaceutical primary standard
API类
brimonidine
形式
powder
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
neat
InChI
1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
InChI key
QZHBYNSSDLTCRG-LREBCSMRSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Brimonidine tartrate USP reference standard for use in specified quality tests and assays.
Also used to prepare standard, system suitability, and sensitivity solutions during the assay, and impurity analysis of brimonidine tartrate.
Also used to prepare standard, system suitability, and sensitivity solutions during the assay, and impurity analysis of brimonidine tartrate.
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
警示用语：
Danger
危险分类
Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
WGK
WGK 3
Brimonidine Tartrate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 42(4), 591-591 (2020)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门